Exploring the Risks and Benefits of Lipid Lowering Therapies

19min Snip

00:00

Play full episode

Summary

Transcript

Episode notes

This chapter discusses the potential risks and benefits of lipid lowering therapies, such as statins, and their impact on cholesterol levels. The speakers emphasize the importance of context and individualized decision making when considering these treatments. They also explore the effects of ketogenic and low carb diets on LDL cholesterol levels and delve into the misconceptions surrounding cholesterol production in the body.

Today, Paul has Dave Feldman on the podcast to discuss, in depth, a recent study that he conducted about LDL and cardiovascular risk and what this may mean for the future of medicine.

*Produced by Mountain Valley Media

00:03:30 The genesis of Dave’s most recent study

00:07:00 is FH a phenotype or genotype polygenetic vs monogenetic

00:22:30 Dave’s overall perspective while conducting studies

0:24:00 Diving into Dave Feldman’s most recent study: Does APOE-B cause atherosclerosis

00:42:30 How the medical community has received this study

00:46:30 Do credentials matter?

00:58:30 Thoughts on Statins

01:04:45 What alters lipid levels

01:13:30 Connect with Dave

References:

Twitter: @realdavefeldman